Clinical trial

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

NCT00298415

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Paclitaxel + Carboplatin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Monotherapy (gemcitabine or vinorelbine) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-03-01

PhasePHASE3

Conditions

NSCLCverified · MONDO: non-small cell lung carcinoma

Interventions

Paclitaxel + CarboplatinDRUG

Monotherapy (gemcitabine or vinorelbine)DRUG

Sponsors & collaborators

Intergroupe Francophone de Cancerologie Thoraciquelead sponsor

Mapped research locations

ParisFrance1 CaenFrance1 GrenobleFrance1 BesançonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00298415 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.